Review Flashcards

1
Q

Urinary incontinence - Types, treatments

A
  1. Stress Incontinence
    - Urethral sphincter unable to prevent flow of urine in the setting of increased intra-abdo pressure
    - Can be damaged during pelvic surgery or rads
    - In women, often due to external (lower urethral) sphincter damage to the pelvic floor
    - Modest incontinence
    - Poor evidence for pharm treatment
    - Antimuscarinic (Tolterodine 2-4mg PO qDaily - poor evidence)
  2. Urge incontinence
    - Inability to control urine flow when detrusor contracts
    - Often without warning
    - Often caused by bladder wall inflammation (infection, tumour invasion, drugs, radiation)
    - Often large volume as bladder may completely empty
    - Catheters very uncomfortable
    - Beta-3-agonists preferred (mirabegron) due to lower side effect profile
    - Solifenacin (anticholinergic)
    - Oxybutynin (smooth muscle relaxant, decreases detrusor instability)
  3. Overflow incontinence
    - Occurs when bladder fills to capacity but cannot contract properly (neuro damage, drugs, outflow obstruction)
    - Causes of outflow obstruction include constipation, prostatic hypertrophy, stricture, or tumour
    - Small, frequent volumes of urine without control
    - High risk of infection with retained urine
    - Treat with alpha adrenergic blockers in men (Terazosin or doxazosin, 1mg qDaily, increase to up to 10mg qDaily) or intermittent cath
  4. Total incontinence
    - Complete loss of sphincter function due to tumour invasion or spinal cord injury
    - Consider self-catheterization or indwelling catheter
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Interactions with methadone

A

Increase methadone levels (Inhibitors):

  • Fluconazole
  • Haldol
  • Verapamil

Decrease methadone levels (INDUCERS)

  • Dexamethasone (>16mg/day)
  • Antiepileptics
  • Carbamazepine, Phenobarb, Phenytoin (could cause opiate withdrawal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What enzyme metabolises methadone

A
  • Hepatic metabolism (Mainly CYP3A4, also 2B6 and others to a lesser extent)
  • Moderate inhibitor of CYP2D6 and CYP 3A4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Serotonin discontinuation syndrome

A
HANGMAN: 
H - headache
A - anxiety
N - nausea
G - gait instability
M - malaise
A - asthenia (fatigue)
N - numbness (paresthesia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Opioid side effects that resolve with time

A
  1. Somnolence/sedation (resolves over days to weeks)
  2. Nausea/vomiting (resolves over days - if it persists, likely not to resolve)
  3. Urinary retention
  4. Respiratory depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Steps for conversion of oxycodone to morphine

A
  1. Current opioid regime and total daily dose
  2. Oxycodone to morphine = multiply by 1.5 for morphine equivalence dose
  3. Dose reduction for incomplete cross tolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Celiac plexus block complications

A

Immediately following:
- Diarrhea (typically transient, rarely necessitating PO opioid)
- Orthostatic hypotension (typically transient, rarely necessitating PO ephedrine 30mg TID)

Catastrophic:

  • Paraplegia (rare occurrence) due to ischemic spinal cord injury from injury or spasm of the artery of Adamkiewicz
  • Aortic dissection
  • Generalised seizures
  • Circulatory arrest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Developmental stages and understanding in children

A
  1. Infancy (0-2)
    - World experienced through sensory input, working on attachment, regulation, and trust in caregivers
    - Will be aware of tension, separation, unfamiliar, and absence
    - Use familiarity, routine, and structure for comfort
  2. Early Verbal Childhood (3-6 years of age)
    - See death as reversible, not personalised. Magical thinking is a hallmark
    - Provide concrete information about the state of being dead, address the concept of guilt (not your fault, can’t catch cancer)
    - Ask how they think their loved one got sick and dispel misconceptions
  3. Middle childhood (7-12 years)
    - Aware of finality of death, causality
    - May struggle with unfairness, abstract/spiritual issues
    - Vulnerable to worries about their health or others, may request graphic details about death and decomposition, may benefit from learning about the illness
  4. Adolescence (>12 years of age)
    - More adult understanding of universality of death, existential/spiritual issues
    - Anticipation and worry about the future
    - May be more self-absorbed about personal implications
    - May struggle with existential issues
    - May engage in risky behaviours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metabolism of codeine

A

CYP3A4 - Norcodeine

UGT2B7 - Codeine-6-glucuronide (main metabolite)

CYP2D6 - Morphine (further metabolised to Normorphine, M-6-G, and M-3-G
*M6G has analgesic effects, while M3G does not and is felt to contribute to neurotoxic adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

EPS and antipsychotics (levels of risk)

A
  1. Typical antipsychotics (most likely)
    - Haldol at higher doses
    - Chlorpromazine
    - Prochlorpromazine
  2. Methotrimeprazine (somewhere in the middle)
  3. Atypical antipsychotics
    - Risperidone (worst offender, more risk with doses > 6mg/day)
    - Quetiapine (most sedating, low risk)
    - Olanzapine (low risk)
  4. Other drugs
    - Maxeran
    - SSRIs
    - SNRIs
    - NDRIs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

DSM Criteria for Delirium

A
  • Disturbance in attention
  • Acute, change in baseline, fluctuates

Must have one disturbance of:

  • Memory deficit
  • Disorientation
  • Language
  • Visuospatial ability
  • Perception
  • Not better explained by a neurocognitive disorder
  • Evidence it is caused by medical condition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Formula for corrected calcium

A

(40-patient albumin)*0.02 + Measured calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatments for hypercalcemia

A

Treatments for hypercalcemia:

Mild (< 3 and asymptomatic or mildly symptomatic)
- Avoid thiazide diuretics, promote PO fluids, avoid calcium supps and vit D

Moderate (3 – 3.5 and asymptomatic or mildly symptomatic)
- Avoid thiazide diuretics, promote PO fluids, avoid calcium supps and vit D

Severe (>3.5, or changes in sensorium)

  • IVF
  • Calcitonin 4 IU/kg (check serum calcium in a few hours to ensure calcitonin sensitive, then repeat q12h) discontinue after 24 – 48 hrs)
  • Zoledronic acid (denosumab if renal function poor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cancers that cause cord compression

A

Breast cancer
Prostate cancer
Multiple Myeloma
Lung cancer

Renal (less commonly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of ongoing hematuria

A
  • CBI in hopes of clot formation (generally first line)
  • Rads

FIRST:

  • Watch to ensure the bladder outlet does not become obstructed which can lead to urosepsis, bladder rupture, and renal failure
  • If a clot occurs, use a hematuria catheter (large diameter, stiff) to evacuate and ensure all clots removed prior to CBI. May require cysto if clots cannot be evacuated.

Other:

  • Alum bladder irrigation (avoid in renal impairment or with very large bladder tumours)
  • Silver nitrate 0.5-1% instilled for 10-20 minutes (risk of ureteral stenosis)
  • Radiation (if from a malignant source)
  • Percutaneous transcatheter arterial embolization (if severe)
  • PO TXA (caution re: clot formation as may lead to obstruction)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Causes of intractable hiccups

A
  • Intracranial neoplasm
  • Esophageal tumour
  • Gastric distention
  • Bowel obstruction
  • Thoracic lymphadenopathy*
  • Uremia
  • Pancreatic CA
  • Drugs (opioids, dexamethasone, chemotherapy - carboplatin)
    (UTD * = more common)
General causes:
Central
- Vascular (stroke, aneurysm)
- Space occupying lesions (tumour, abscess)
- Head trauma
- Encephalitis
- Neurodegenerative (MS, PD)

Peripheral

  • Esophageal (dilatation, achalasia, tumour, food impaction)
  • GI (distention, gastritis, reflux, SBO, ascites, peritoneal traction)
  • Hepatic (liver mets/primary Ca, abscess, cholecystitis)
  • Iatrogenic (benzos, opioids, steroids, chemo)
  • Respiratory (diaphragmatic irritation - pna, effusion, subphrenic abscess)
  • Toxic/metabolic (renal failure, EtOH, lytes, hypoadrenalism)
  • Infectious (herpes zoster, GI candidiasis)
  • Cardiac (MI)
  • Psychological
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tenesmus treatment

A
  • Opioids
  • Topical or oral Calcium channel blockers (diltiazem gel or nifedipine)
  • Belladonna and opium suppositories
  • Steroids (radiation proctitis)
  • Antispasmodic - Buscopan
  • Topical analgesics - rectal enema of lidocaine 2% gel
  • NTG if a fissure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Parkinsonism-hyperpyrexia syndrome

A

Withdrawal syndrome/Parkinsonism-hyperpyrexia syndrome

  • Occurs due to suppression of dopaminergic system
  • Essentially manifests as NMS with pyrexia, muscular rigidity, reduced LOC, autonomic instability
  • Treat with reinstatement of usual antiparkinsonian meds (may need to occur via NG)
  • If no response, consider TD rotigotine
19
Q

Topical treatments for the management of bleeding associated with a malignant wound

A
  • Calcium alginates
  • collagen dressings
  • Topical thromboplastin
  • Silver nitrate cautery
  • Zinc chloride paste (applied topically to fungating breast wounds)
  • Topical TXA
20
Q

Treatment of malodorous wounds

A
  1. Metronidazole (topical or systemic)
    - No RCTs for PO, give 250-500mg PO BID
    - PO Metronidazole cheaper than topical
  2. Odour absorbent dressings
    - Contain layer of activated charcoal
    - Charcoal layer must be kept dry, outermost dressing must be air tight
  3. Wound cleansing/debridement
  4. Environmental control
21
Q

Indications and contraindications for lidocaine

A

Lidocaine indications:

  • Refractory pain to typical opioids and adjuvants
  • Neuropathic pain
  • Dose limiting side effects of opioids and adjuvants
  • Pain crisis secondary to neuropathic pain requiring acute therapy

Exclusion criteria

  • Adequate LOC to report pain intensity and effect
  • Prior allergy
  • Liver failure
  • Cardiac failure or heart block (2nd or above)
  • Uncontrolled seizures
  • BP > 160
  • Hypokalemia
22
Q

Complications of a celiac plexus block

A

Immediately following:

  • Diarrhea (typically transient, rarely necessitating PO opioid)
  • Orthostatic hypotension (typically transient, rarely necessitating PO ephedrine 30mg TID)

Catastrophic:

  • Paraplegia (rare occurrence) due to ischemic spinal cord injury from injury or arterial spasm
  • Aortic dissection
  • Generalised seizures
  • Circulatory arrest
23
Q

Receptors antipsychotics act on

A
Dopamine 1
Dopamine 2
Histamine 1
Serotonergic (5HT2, 5HT3)
Acetylcholine (M1, M2)
Alpha-1-adrenergic
24
Q

Mechanisms of hypercalcemia

A
  1. Secretion of parathyroid hormone-related protein stimulating osteoclastic bone resorption
  2. Bony metastases with release of osteoclast activating factors
  3. Calcitriol production secondary to hematologic malignancies (increases GI absorption)
  4. Ectopic PTH secretion (rare)
25
Q

Side effects of steroids

A
  1. CNS
    - euphoria, anxiety, insomnia, psychosis
  2. MSK
    - osteoporosis, steroid myopathy
  3. Derm
    - skin thinning, striae, ecchymoses, acne, atrophy
  4. Endocrine
    - hyperglycemia (increased gluconeogenesis, insulin resistance), adrenal suppression*
  5. CV
    - hypertension
  6. GI
    - gastritis, PUD, GI bleeding
  7. Immune
    - immunocompromise with increased risk of infection*
26
Q

Adverse effects of cannabis and contraindicatiosn to use

A

Contraindications to medical cannabis oil:

  • Hypersensitivity to cannabinoids
  • Severe CV or cerebrovascular disease (risk of hypo/hypertension, syncope, tachycardia, MI and stroke)
  • Severe liver disease
  • Severe renal disease
  • Personal history of mood disorders or psychosis (especially with THC)

Adverse effects:

  • Dependence (physical or psychological)
  • Somnolence
  • Dry mouth
  • Tachycardia
  • Anxiety
  • Nausea
27
Q

Clinical features of neuroleptic malignant syndrome and lab diagnosis

A

Neuroleptic malignant syndrome

  • Fever
  • Encephalopathy
  • Vital sign instability
  • Rigidity

*No myoclonus as in serotonin syndrome, look for abnormal BW and severe rigidity

Labs:

  • Creatine kinase
  • White blood cell count
28
Q

Treatment for hiccups

A

Warranted for hiccups >48 hrs
Consider Rx of underlying cause (e.g. PPI for GERD)

First line

  • Baclofen 5-10mg TID (smooth muscle relaxant)
  • Metoclopramide 10mg PO TID (dopamine antagonist)
  • Gabapentin 100mg TID (increasing GABA release)

Others
- Chlorpromazine 25mg PO TID (approved by FDA for intractable hiccups, but has more side effects and is no longer considered first line)

Typically, use for 5-10 days and stop the day after hiccups stopped. Some patients may require the medication indefinitely

29
Q

Neuropathic pain treatment

A
  1. Gabapentinoid (unless patient is depressed, in which case go straight to antidepressants). Note that pregabalin (Lyrica) is more rapidly and predictably absorbed.
  2. Analgesic antidepressants (Duloxetine is first line, then try a TCA)
  3. Steroids (consider more for short term pain crisis)
  4. Topical lidocaine 5% if localised
  5. If opioids are required due to moderate/severe pain, start with an IR opioid while adjuvants are being initiated and then switch to long acting once pain regime is stablised. NNT for opioids 2.6-5.1
30
Q

Conditions impacting the pharmacokinetics of fentanyl?

A
  • Hepatic impairment
  • Obesity (larger volume of distribution)
  • Elderly age (reduced hepatic bloodflow)
  • Renal impairment (note generally thought to be safe)
  • Hyperthermia
31
Q

ESRD symptoms

A
  • Pain
  • Agitation
  • Confusion
  • Dyspnea
  • Nausea
  • Myoclonus
  • Pruritus
  • Restless legs
  • Fatigue
  • Weakness
32
Q

Treatment of spasticity

A
  • Baclofen (first line)
  • Tizanidine (second line)
  • Diazepam (second line)
  • Botox
33
Q

Indications for ketamine in the palliative setting

A
  • Neuropathic pain
  • Opioid refractory pain
  • Intolerable side effects to opioids
34
Q

Mechanism of action: Acetaminophen

A

COX inhibition, preventing prostaglandin synthesis

35
Q

Mechanism of action: NSAIDs

A

NSAIDs: COX inhibition; prevention of conversion of arachidonic acid to prostaglandins

36
Q

Mechanism of action: Glucocorticoids

A

Glucocorticoids: decreases inflammation by suppression of inflammatory mediators and neutrophil migration

37
Q

Mechanism of action: Ketamine

A

Ketamine: NMDA receptor antagonism

38
Q

Mechanism of action: TCA

A

TCA: serotonin and norepinephrine reuptake inhibitors

39
Q

Mechanism of action: Bisphosphonates

A

Bisphosphonates: Inhibit osteoclast mediated bone resorption

40
Q

Treatment of drooling in ALS

A

Pharmacological:

  • Atropine
  • Glycopyrrolate
  • Scopolamine
  • Botox

Non-pharmacological:

  • Salivary gland duct relocation
  • Radiation
  • Neurectomy
  • Suction
41
Q

Immunotherapy side effects

A
Skin: dermatitis
Colon: colitis
Liver: hepatotoxicity/hepatitis
Lungs: pneumonitis
Thyroid: hyper or hypothyroidism
Pituitary: hypophysitis
Adrenal insufficiency
42
Q

Cord compression - treatment decisions

A
  1. Radiation versus surgery and radiation
    - Radiosensitivity
    - Unstable spine (surgery preferred)
    - Retropulsion of bone fragments (surgery preferred)
    - Prognosis > 3 months makes surgery
    preferred
    - Performance status prior to onset of symptoms (better PS makes surgery more acceptable)
    - Progression despite rads
  2. Adjuvant treatments
    - Steroids
    - Analgesia
43
Q

Tumours associated with hypercalcemia

A
  1. Myeloma
  2. Breast
  3. Lung
  4. Renal

Also:

  • Lymphoma
  • Prostate
  • Bladder